{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T04:22:43Z","timestamp":1781151763270,"version":"3.54.1"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,2]]},"abstract":"<jats:p>Staging of renal pelvic urothelial carcinoma can be challenging due to anatomic variation at the renal pelvis compared with ureter and bladder and calls into question the prognostic accuracy of the current TNM staging. In this study, we determined staging and cancer-specific survival (CSS) in 141 patients undergoing nephroureterectomy for renal pelvic urothelial carcinoma (pTa=50, pT1=29, pT2=10, pT3=36, and pT4=16). Under current staging criteria, we found no significant difference in CSS between adjacent staging categories step-wise across pTa, pT1, pT2, and pT3 tumors. When pT3 tumors were subcategorized into renal medulla, peripelvic adipose, or renal cortex invasion with or without peripelvic adipose invasion, we found that cortical invasion was associated with significantly worse CSS compared with medulla or peripelvic adipose invasion only. We next revised staging criteria such that pT1 correlated with invasion of lamina or muscularis propria (n=37), T2 with invasion of medulla or peripelvic adipose only (n=26), and pT3 with cortical invasion (n=12). Under the new criteria, better separation of survival curves was achieved; however, pT1 and pT2 remained statistically insignificant. When further redefining pT3 as invasive of cortex only (n=12) and combining medulla with lamina and muscularis propria invasion as a lower stage (pT1, n=63), there was further improvement in the prognostic stratification. Therefore, our data show that consideration of revised and simplified T staging criteria at the renal pelvis is warranted, wherein invasion of any anatomic structure up to the cortex shows a similar prognosis (combined pT1 category) and invasion of cortex showing significantly worse prognosis (pT3).<\/jats:p>","DOI":"10.1097\/pas.0000000000002331","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T06:00:08Z","timestamp":1731564008000},"page":"113-120","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":1,"title":["A Proposal for Revised and Simplified Renal Pelvic Urothelial Carcinoma Staging Criteria"],"prefix":"10.1097","volume":"49","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1067-0561","authenticated-orcid":false,"given":"Miranda E.","family":"Machacek","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanzhang","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Devins","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter M.","family":"Sadow","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chin-Lee","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Oliva","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Saylor","sequence":"additional","affiliation":[{"name":"Department of Medicine, Massachusetts General Hospital Cancer, Boston, MA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine M.","family":"Cornejo","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,11,14]]},"reference":[{"key":"R1-20250115","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00345-016-1928-x","article-title":"Epidemiology, diagnosis, preoperative evaluation and prognostic assessment of upper-tract urothelial carcinoma (UTUC)","volume":"35","author":"Soria","year":"2017","journal-title":"World J Urol"},{"key":"R2-20250115","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1016\/j.juro.2012.05.079","article-title":"Urothelial carcinoma of the bladder and the upper tract: disparate twins","volume":"189","author":"Green","year":"2013","journal-title":"J Urol"},{"key":"R3-20250115","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1158\/1078-0432.CCR-18-2039","article-title":"Clonal relatedness and mutational differences between upper tract and bladder urothelial carcinoma","volume":"25","author":"Audenet","year":"2019","journal-title":"Clin Cancer Res"},{"key":"R4-20250115","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/j.eururo.2015.07.039","article-title":"Genomic characterization of upper tract urothelial carcinoma","volume":"68","author":"Sfakianos","year":"2015","journal-title":"Eur Urol"},{"key":"R5-20250115","doi-asserted-by":"crossref","first-page":"1097730","DOI":"10.3389\/fimmu.2022.1097730","article-title":"Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy","volume":"13","author":"Tang","year":"2022","journal-title":"Front Immunol"},{"key":"R6-20250115","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.eururo.2020.05.042","article-title":"European Association of Urology Guidelines on upper urinary tract urothelial carcinoma: 2020 update","volume":"79","author":"Roupr\u00eat","year":"2021","journal-title":"Eur Urol"},{"key":"R7-20250115","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1016\/j.humpath.2007.03.012","article-title":"A proposal for a novel staging system in renal pelvicaliceal urothelial carcinomas","volume":"38","author":"Cho","year":"2007","journal-title":"Hum Pathol"},{"key":"R8-20250115","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1002\/cncr.10609","article-title":"Prognostic impact of extensive parenchymal invasion pattern in pT3 renal pelvic transitional cell carcinoma","volume":"94","author":"Yoshimura","year":"2002","journal-title":"Cancer"},{"key":"R9-20250115","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.juro.2007.03.115","article-title":"The impact factors on prognosis of patients with pT3 upper urinary tract transitional cell carcinoma","volume":"178","author":"Wu","year":"2007","journal-title":"J Urol"},{"key":"R10-20250115","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.juro.2009.05.040","article-title":"The protective role of renal parenchyma as a barrier to local tumor spread of upper tract transitional cell carcinoma and its impact on patient survival","volume":"182","author":"Park","year":"2009","journal-title":"J Urol"},{"key":"R11-20250115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/j.1365-2559.2012.04183.x","article-title":"Is pT3 urothelial carcinoma of the renal pelvis a homogeneous disease entity? Proposal for a new subcategory of the pT3 classification","volume":"61","author":"Sassa","year":"2012","journal-title":"Histopathology"},{"key":"R12-20250115","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eururo.2012.01.019","article-title":"Subclassification of pT3 urothelial carcinoma of the renal pelvicalyceal system is associated with recurrence-free and cancer-specific survival: proposal for a revision of the current TNM classification","volume":"62","author":"Shariat","year":"2012","journal-title":"Eur Urol"},{"key":"R13-20250115","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/s00345-013-1073-8","article-title":"Peripelvic\/periureteral fat invasion is independently associated with worse prognosis in pT3 upper tract urothelial carcinoma","volume":"32","author":"Park","year":"2014","journal-title":"World J Urol"},{"key":"R14-20250115","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.juro.2014.04.001","article-title":"Reassessment of prognostic heterogeneity of pT3 renal pelvic urothelial carcinoma: analysis in terms of proposed pT3 subclassification systems","volume":"192","author":"Park","year":"2014","journal-title":"J Urol"},{"key":"R15-20250115","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.purol.2013.12.005","article-title":"Pronostic value of parenchyma renal invasion of pT3 upper tract urinary carcinoma","volume":"24","author":"Bruzzi","year":"2014","journal-title":"Prog Urol"},{"key":"R16-20250115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00428-020-02973-8","article-title":"pT3 subclassification of renal pelvic cancer considering the tumor location improves the patients\u2019 prognostic accuracy","volume":"478","author":"Sano","year":"2021","journal-title":"Virchows Arch"},{"key":"R17-20250115","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1016\/j.euf.2020.10.004","article-title":"Prognostic impact of pT3 subclassification in a multicentre cohort of patients with urothelial carcinoma of the renal pelvicalyceal system undergoing radical nephroureterectomy: a propensity score-weighted analysis after central pathology review","volume":"7","author":"Seisen","year":"2021","journal-title":"Eur Urol Focus"},{"key":"R18-20250115","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.humpath.2022.03.004","article-title":"Reclassifying pT3 renal pelvic urothelial carcinoma with renal parenchyma invasion to pT2 improves correlation with overall survival","volume":"125","author":"Wu","year":"2022","journal-title":"Hum Pathol"},{"key":"R19-20250115","doi-asserted-by":"crossref","first-page":"100140","DOI":"10.1016\/j.modpat.2023.100140","article-title":"Renal pelvic urothelial carcinoma with invasion into renal medulla can be redefined as pT2 to improve correlation with survival","volume":"36","author":"Wong","year":"2023","journal-title":"Mod Pathol"},{"key":"R20-20250115","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1016\/j.juro.2009.07.035","article-title":"Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma","volume":"182","author":"Isbarn","year":"2009","journal-title":"J Urol"},{"key":"R21-20250115","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1016\/j.eururo.2009.07.002","article-title":"Impact of tumor location on prognosis for patients with upper tract urothelial carcinoma managed by radical nephroureterectomy","volume":"57","author":"Raman","year":"2010","journal-title":"Eur Urol"},{"key":"R22-20250115","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/j.1464-410X.2012.10930.x","article-title":"International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvis","volume":"110","author":"Roscigno","year":"2012","journal-title":"BJU Int"},{"key":"R23-20250115","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12894-018-0334-7","article-title":"Comparison of clinicopathologic characteristics, epigenetic biomarkers and prognosis between renal pelvic and ureteral tumors in upper tract urothelial carcinoma","volume":"18","author":"Fang","year":"2018","journal-title":"BMC Urol"},{"key":"R25-20250115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1111\/j.1365-2559.2006.02478.x","article-title":"The human renal lymphatics under normal and pathological conditions","volume":"49","author":"Ishikawa","year":"2006","journal-title":"Histopathology"},{"key":"R26-20250115","doi-asserted-by":"crossref","first-page":"23.e1","DOI":"10.1016\/j.urolonc.2012.08.010","article-title":"Influence of previous or synchronous bladder cancer on oncologic outcomes after radical nephroureterectomy for upper urinary tract urothelial carcinoma","volume":"32","author":"Pignot","year":"2014","journal-title":"Urol Oncol"},{"key":"R27-20250115","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/S0140-6736(20)30415-3","article-title":"Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial","volume":"395","author":"Birtle","year":"2020","journal-title":"Lancet"},{"key":"R28-20250115","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1200\/JCO.23.01659","article-title":"Improved disease-free survival with adjuvant chemotherapy after nephroureterectomy for upper tract urothelial cancer: final results of the POUT trial","volume":"42","author":"Birtle","year":"2024","journal-title":"J Clin Oncol"},{"key":"R29-20250115","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa2034442","article-title":"Adjuvant nivolumab versus placebo in muscle-invasive urothelial carcinoma","volume":"384","author":"Bajorin","year":"2021","journal-title":"N Engl J Med"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002331","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T06:00:26Z","timestamp":1736920826000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000002331"}},"subtitle":["A Clinicopathologic Study of 141 Tumors"],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000002331","relation":{},"ISSN":["0147-5185","1532-0979"],"issn-type":[{"value":"0147-5185","type":"print"},{"value":"1532-0979","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}